US 11098054
Englerin derivatives for treatment of cancer
granted A61PA61P35/00
Quick answer
US patent 11098054 (Englerin derivatives for treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Sciences expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Sciences
- Grant date
- Tue Aug 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P35/00